SME
Description
KINETO Lab Ltd. is a biotechnology Contract Research Organization (CRO) specializing in in vivo preclinical studies, supporting the development of innovative drugs and therapeutic solutions across multiple disease areas. The company operates in strict alignment with the 3Rs principles (Replacement, Reduction, Refinement), ensuring that all animal-based research is conducted ethically while maintaining high scientific standards and delivering robust, reproducible, and internationally compliant preclinical data. KINETO Lab provides custom-designed animal models and fully tailored study execution, focusing on the evaluation of both efficacy and safety of drug candidates, with a primary emphasis on oncology and anticancer therapies, while also offering capabilities in other disease areas. These studies play a critical role in de-risking drug development by enabling the validation of new compounds before they advance to clinical trials. The company’s target clients include pharmaceutical companies (Big Pharma), small and medium-sized enterprises (SMEs), and academic institutions involved in drug development and translational research, for whom KINETO Lab acts as a flexible and strategic partner, accelerating the transition from early discovery to clinical application.
